Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

Share Price Information for Craven House Capital (CRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.20
CRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan Acquisition & Issue of Equity

28 May 2013 15:12

RNS Number : 7187F
Craven House Capital PLC
28 May 2013
 



28 May 2013

Craven House Capital Plc

("Craven House" or the "Company")

 

Loan Acquisition

Issue of Equity

 

The Company today announces that it has signed an agreement to acquire, at a small fraction of its nominal value, a distressed loan (the "Loan") in the 3 Star Green Isle Conference and Leisure Hotel in Dublin (the "Hotel").

 

The Hotel has 270 bedrooms, as well as conference and leisure facilities, and recently was independently valued at between €3.5m and €5m. Following the acquisition of the Loan, which is being acquired for a cash consideration of €0.7 million, Craven House will be the sole secured lender for the Hotel and will then lead a restructuring of the remaining unsecured creditors.

 

Under the original terms of the Loan, the Hotel was due to pay an annual interest charge of approximately €250,000 per annum. The directors of Craven House believe that the Hotel can be a profitable going concern and, post the restructuring, can generate more than sufficient cash-flow to service a significant annual interest payment to Craven House, resulting in a substantial increase in the Company's annual revenues.

 

Desmond Holdings Ltd ("Desmond"), the Company's Investment Manager, will lend the Company the €700,000 required to complete the transaction at a rate of 6% per annum (the "Desmond Loan"). The Desmond Loan is repayable after a period of two years and can also be converted into equity in Craven House (at a price of 1.25p per share) at Craven House's discretion.

 

Desmond is a substantial shareholder in the Company and Mark Pajak is a director and shareholder in Desmond. Accordingly, the Desmond Loan constitutes a related party transaction under AIM Rule 13. The independent directors of the Company, having consulted with Daniel Stewart & Company plc, the Company's nominated adviser, consider that the terms of the transaction are fair and reasonable as far as shareholders are concerned.

 

Mark Pajak, Acting Chairman, commented, "It is core theme of the Company's investing policy to acquire interests in cash generative assets. The directors believe that the Hotel is such an asset and has the ability, post-restructuring, to significantly increase the Company's revenues and cash flows; with the additional potential of capital appreciation through having acquired the Loan at a significant discount to the underlying asset value."

 

The Company also announces the issue of 730,000 new ordinary shares of 0.1p each in the share capital of the Company, at a price of 1.25p per ordinary share, in lieu of fees of £9,125 ("New Ordinary Shares"). Application has been made to the London Stock Exchange for the New Ordinary Shares and admission is expected to take place on 3 June 2013. The New Ordinary Shares will rank parri passu with the existing issued ordinary shares. 

 

Following the issue of the New Ordinary Shares, the Company's total issued share capital will consist of 592,695,959 Ordinary Shares with each share carrying the right to one vote. The Company has no Ordinary Shares held in treasury. The total of 592,695,959 Ordinary Shares may therefore be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

 

 For further information please contact:

 

Craven House Capital Plc:

 

www.cravenhousecapital.com

 

 

Alexandra Eavis

Non Executive Director & Company Secretary

 

Tel: 07590 831 323

 

 

Daniel Stewart & Company Plc:

(Nominated Adviser & Broker)

 

Antony Legge/James Thomas

Tel: 020 7776 6550

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFLSELITFIV
Date   Source Headline
28th Feb 20247:00 amRNSInterim Results
4th Jan 20247:00 amRNSResult of Annual General Meeting
29th Nov 20232:48 pmRNSAnnual Results for year ended 31 May 2023
28th Nov 20234:08 pmRNSInvestee Companies' Update
16th Nov 20239:07 amRNSInvestee Companies’ Update: Garimon and Honeydog
23rd Oct 20237:00 amRNSInvestee company update: Bio Vitos
17th Oct 20237:46 amRNSInvestee Companies’ Update: Garimon and Honeydog
29th Aug 20231:34 pmRNSInvestee company update: Bio Vitos
3rd Jul 20231:32 pmRNSInvestee company update: Bio Vitos
3rd Mar 20236:15 pmRNSPortfolio Update
27th Feb 20233:30 pmRNSInterim Results
8th Feb 20237:00 amRNSInvestee company update: Bio Vitos
27th Jan 202311:33 amRNSResult of Annual General Meeting
29th Nov 20227:00 amRNSAnnual Results for Year Ended 31 May 2022
15th Nov 20222:42 pmRNSInvestee company update: Garimon Ltd
23rd Feb 20223:01 pmRNSInterim Results
21st Jan 202212:45 pmRNSResult of AGM
23rd Dec 20213:59 pmRNSNotice of AGM
29th Nov 20216:29 pmRNSAnnual Results for year ended 31 May 2021
24th Nov 20212:55 pmRNSInvestee company update: OneBas.Com Ltd.
26th Oct 20217:00 amRNSInvestee company update: YRRO Ltd
16th Mar 20211:06 pmRNSTR-1: Notification of major holdings
18th Feb 20213:07 pmRNSInterim Results
11th Feb 202111:21 amRNSTR-1: Notification of major holdings
5th Feb 202110:44 amRNSStatement Regarding Share Price Movement
18th Jan 20212:49 pmRNSResult of Annual General Meeting
21st Dec 20207:00 amRNSNotice of General Meeting
9th Dec 20207:00 amRNSInvestee Company Update: YRRO Ltd
3rd Dec 202012:43 pmRNSAnnual Results for year ended 31 May 2020
9th Nov 20209:45 amRNSChange of Auditor
9th Oct 20203:14 pmRNSTrading Update, Change of Auditor & 2020 Results
18th Sep 202010:57 amRNSInvestee company update: Magazinos.com
22nd Jun 20201:01 pmRNSTR-1: Notification of major holdings
18th Jun 202011:06 amRNSSecond Price Monitoring Extn
18th Jun 202011:00 amRNSPrice Monitoring Extension
3rd Jun 20201:27 pmRNSTR-1: Notification of major holdings
1st Jun 20202:05 pmRNSSecond Price Monitoring Extn
1st Jun 20202:00 pmRNSPrice Monitoring Extension
22nd May 20209:43 amRNSResult of General Meeting
5th May 202010:42 amRNSTR-1: Notification of major holdings
1st May 202010:58 amRNSPosting of Circular
1st Apr 20203:39 pmRNSCoronavirus and Business Update
23rd Mar 202012:19 pmRNSOn-line Platform Launched by Investee, Rosedog Ltd
20th Mar 20205:01 pmRNSNotification of major holdings
13th Mar 20207:00 amRNSSimultaneous exercise of five Option Agreements
27th Feb 202011:22 amRNSIssue of Equity and Directors' Dealing
27th Feb 20207:00 amRNSInterim Results
25th Feb 20209:16 amRNSNotification of major holdings
24th Feb 20207:00 amRNSCraven House signs 5 Non-binding Option Agreements
18th Feb 20202:54 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.